<?xml version="1.0" encoding="UTF-8"?>
<p id="p0205">Basically, to reach an efficient cell-mediated antitumor response is necessary to exploit pre-existing immunity to enhance oncolytic immunotherapy. This highlights the importance of the interplay between the innate and adaptive arm of the immune system as well as the key role of effector memory CD4 + T cells in supporting the ongoing anti-tumour response.</p>
